Intrathecal chemical neurolysis for intractable cancer pain: a retrospective audit of 39 patients at a specialized cancer centre

  • Saad Ur Rehman
Keywords: Cancer pain, Pain intervention, Intrathecal chemical neurolysis

Abstract

Objectives: Treatment of cancer pain presents a challenging problem. Up to 90% of cancer patients can be treated with conventional pharmacological therapy. The remaining 10% of patients require additional interventions for management of their pain. Intrathecal chemical neurolysis(ICN) is a beneficial intervention in management of cancer pain. The primary objective of this study was to study the effects of pain relief of ICN on the Visual Analogue Score (VAS) of patients with metastatic cancer disease on palliative therapy.

Published
06-13-2019
How to Cite
Rehman, S. U. (2019). Intrathecal chemical neurolysis for intractable cancer pain: a retrospective audit of 39 patients at a specialized cancer centre. Anaesthesia, Pain & Intensive Care. Retrieved from https://apicareonline.com/index.php/APIC/article/view/816
Section
SHORT COMMUNICATION